Search

The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a “public option” for clinical trials.

Summary

A public option is a government-provided social good that exists alongside a similar, privately provided good. For example, in American public policy debates over the Affordable Care Act, some scholars and policymakers advocated for a publicly provided health insurance option (like Medicare) that could coexist alongside private health insurance options; individuals would be able to choose between the public option and private options. While the public option is typically identified with health care policy, public options have actually been a longstanding feature of American life in a variety of sectors. Public schools coexist with private schools; public swimming pools are an accessible alternative to building a pool in the backyard; public libraries provide an option to get a wide variety of books without purchasing them for one’s personal library.

Search Results

Refine search

Refine search

Actions for selected content:

2 results

A Public Option for Clinical Trials? Lessons from Convalescent Plasma

Introduction

Summary

Search Results

Refine search

Refine search

Actions for selected content:

Save Search

2 results

A Public Option for Clinical Trials? Lessons from Convalescent Plasma

Introduction

Summary